Amal.Bo

AMAL.BO maintains a strong liquidity position, with a current ratio of 2.48, indicating the company can comfortably cover its short-term liabilities with its short-term assets. The company's liquidity FPT (Free Cash Flow to Total Liabilities) is robust, supported by a free cash flow of INR 236.2 million and total liabilities of INR 337.995 million. The valuation snapshot shows a market price of INR 554, with a price-to-book ratio of 5.69, suggesting the company is trading at a premium to its book value.

Profitability metrics for AMAL.BO are strong, with a return on equity (ROE) of 18.6% and a return on assets (ROA) of 14.52%, both exceeding the typical thresholds for the Commodity Chemicals industry. The company's operating income of INR 263.597 million and net income of INR 223.844 million reflect solid operational performance. Gross profit of INR 514.727 million indicates efficient cost management, although the gross margin is not explicitly stated, it is implied to be in line with industry norms.

The company's revenue is primarily concentrated in the Commodity Chemicals segment, with no disclosed geographic diversification. This concentration may expose the company to sector-specific risks, such as commodity price volatility and regulatory changes. The lack of geographic diversification could limit growth opportunities in the event of regional economic downturns.

AMAL.BO's growth trajectory is positive, with a revenue of INR 2,396.374 million in the latest reporting period. While no specific growth rate is provided, the company's strong operating cash flow of INR 216.956 million and free cash flow of INR 236.2 million suggest a capacity for reinvestment and expansion. The company's capital expenditure of INR -68.332 million indicates a reduction in capital spending, which may signal a focus on maintaining current operations rather than aggressive expansion.

Risk factors for AMAL.BO are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.0, indicating no leverage, which reduces financial risk. However, the absence of debt may also limit the company's ability to leverage growth opportunities. The risk assessment also notes low dilution potential, with no near-term pressure from share issuance or other dilutive events.

Recent events for AMAL.BO include the latest financial reporting period, which shows strong performance across key financial metrics. The company's financial health is supported by a solid balance sheet, with total assets of INR 1,541.751 million and total equity of INR 1,203.756 million. The company's market cap of INR 6,848.915 million reflects investor confidence in its operations and future prospects.

Net income grew at a 10% CAGR from FY2023 to FY2025, demonstrating consistent profitability expansion over the period.

Free cash flow reached $134.4 million in FY2025, indicating strong cash generation capabilities for the financial institution.

Analysts assign a mean price target of $51, implying 4.8% upside from the current market price of $48.66.

The company exhibits low liquidity and dilution risks, suggesting a stable capital structure and shareholder value protection.

Cash conversion ratio of 2.25 exceeds the bank cohort median of 1.15, highlighting superior efficiency in generating cash.

Total assets declined by 6.9% year-over-year in FY2025, signaling a shrinking balance sheet and potential business contraction.

Equity decreased by 10.9% year-over-year in FY2025, reflecting a substantial reduction in shareholder capital base.

Free cash flow dropped 9.0% year-over-year in FY2025, suggesting weakening cash generation trends despite income growth.

Return on assets of 0.28% is extremely low, indicating minimal profitability relative to the total asset base employed.